Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
The Effect of Post-Discharge Multiple Nursing Interventions on the Number of Hospital Admissions, Dyspnea Level, and Quality of Life in COPD Patients Receiving Home Oxygen Therapy: A Randomized Controlled Study
1 other identifier
interventional
74
1 country
1
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity and mortality associated with COPD acute exacerbations represent a significant public health problem that places a high burden on patients, their families and society. In frequent and severe exacerbations, patients may experience a decrease in quality of life, depression, and even death up to one year after hospitalization. Costs associated with COPD are more than $15.5 billion, and hospitalizations and repeated hospital admissions related to acute exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce hospital admissions and hospitalizations associated with recurrent exacerbations are imperative to improve patient's quality of life and reduce the societal burden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedStudy Start
First participant enrolled
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedNovember 22, 2024
November 1, 2024
6 months
January 25, 2023
November 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
number of hospital admissions
Number of hospital admissions
At the end of the 1st month.
number of hospital admissions
Number of hospital admissions
At the end of the 3st month.
number of hospital admissions
Number of hospital admissions
At the end of the 6st month.
Secondary Outcomes (6)
Scores from the mMRC Dyspnea scale (on the first encounter)
At the end of the 1st month.
Scores from the mMRC Dyspnea scale (on the first encounter)
At the end of the 3st month.
Scores from the mMRC Dyspnea scale (on the first encounter)
At the end of the 6st month.
Scores from the St George Respiratory Questionnaire
At the end of the 1st month.
Scores from the St George Respiratory Questionnaire
At the end of the 3st month.
- +1 more secondary outcomes
Study Arms (2)
intervention group
EXPERIMENTALWithin the scope of the pre-test, the researcher to the patients who will explain the purpose of the research and agree to participate in the research; Inclusion Criteria Form; Socio-Demographic Information Form; Patient Descriptive Information Form, Modified British Medical Research Council (MRC) Questionnaire, St George Respiratory Questionnaire (Quality of Life Scale) will be used to evaluate patients' symptoms. In addition, the patients in the intervention group will be educated with the training booklet "Educational Guide for COPD Patients" prepared by the researcher by scanning the literature.
Not intervention group
NO INTERVENTIONThe control group will be subjected to the standard COPD training given in the hospital and no intervention will be made by the researcher. After the trials of the experimental group are completed, the control group will be given a home visit, a COPD training booklet, and audio-visual materials.
Interventions
Health Education: While they are still in the hospital, a 30-minute individually planned education about their disease will be given to patients using the COPD patient education booklet. step 1. Smoking cessation, step 2. Vaccination, step 3. Correct drug use, step 4. Regular exercise, step 5. Healthy eating, step 6. Coping with stress, step 7 Coping with attacks, step 8. Includes regular oxygen therapy. Let's learn nhaverug treatments in coping with COPD, under the title of pulmonary rehabilitation (Respiratory Rehabilitation), methods of coping with shortness of breath, indoor air pollution and outdoor air pollution subheadings.
A group will be created through the WhatsApp application for participants in health education and visual and audio materials will be shared through this group every week. In the coming weeks, the researcher will provide consultancy services to those who have problems with the application.
Participants will be called every month by the researcher and asked if there are any hospital visits in that month, especially if they are chest disease visits.
Eligibility Criteria
You may qualify if:
- Being diagnosed with stage 4 (group D) COPD according to GOLD criteria
- Being 18 years or older,
- Having a video computer, tablet or phone,
- Having an internet connection at home or on the phone,
- Residing in the city centre of Konya,
- Not having a communication problem, such as an inability to understand/speak Turkish, that would prevent participation in the research,
- Being literate,
- Using an oxygen concentrator at home.
You may not qualify if:
- Being illiterate,
- Being diagnosed with first, second and third-stage COPD according to GOLD criteria,
- Having another lung disease in addition to COPD (Lung cancer-Asthma, etc.),
- Having physical and/or mental disabilities,
- Being visually impaired and/or hearing impaired,
- Having a communication problem that prevents participation in the research, such as an inability to understand/speak Turkish,
- Having been diagnosed with Covid-19 or having had it in the past,
- Having a psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Selçuk Tıp Fakültesi Hastanesi
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DİLEK CİNGİL
https://erbakan.edu.tr/hemsirelikfak
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 15, 2023
Study Start
February 15, 2023
Primary Completion
August 15, 2023
Study Completion
December 31, 2024
Last Updated
November 22, 2024
Record last verified: 2024-11